Status:
RECRUITING
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Lead Sponsor:
Pfizer
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab...
Detailed Description
This is a single-arm elranatamab post-trial access study. Participants will receive elranatamab. All participants will receive elranatamab until disease progression, unacceptable toxicity, withdrawal ...
Eligibility Criteria
Inclusion
- Participants must agree to follow the reproductive criteria as outlined in the protocol
- Participants have completed a qualifying Parent Study, were still receiving elranatamab when the Parent Study terminated or completed, and are deriving clinical benefit from elranatamab (as determined by the investigator).
Exclusion
- Any medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
- Participants not previously enrolled or who have discontinued study treatment in a Parent Study are ineligible for participation in this study.
Key Trial Info
Start Date :
October 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 22 2032
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06057402
Start Date
October 3 2023
End Date
February 22 2032
Last Update
December 22 2025
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
UCHealth Poudre Valley Hospital
Fort Collins, Colorado, United States, 80524
2
UCHealth Harmony
Fort Collins, Colorado, United States, 80528
3
UCHealth Greeley Hospital
Greeley, Colorado, United States, 80634
4
Longs Peak Hospital
Longmont, Colorado, United States, 80504